These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 19685798)

  • 1. Making big drugs. Interview by Geoff Colvin.
    Sharer K
    Fortune; 2009 Jul; 160(2):31-6. PubMed ID: 19685798
    [No Abstract]   [Full Text] [Related]  

  • 2. Profile: Corey Goodman.
    Kling J
    Nat Biotechnol; 2009 Apr; 27(4):308. PubMed ID: 19352358
    [No Abstract]   [Full Text] [Related]  

  • 3. Alejandro Zaffaroni (1923-2014).
    Shaw JE
    Nature; 2014 Apr; 508(7495):187. PubMed ID: 24717508
    [No Abstract]   [Full Text] [Related]  

  • 4. An interview with Martin Rosenberg, Ph.D. Interviewed by Vicki Glaser.
    Rosenberg M
    Assay Drug Dev Technol; 2009 Dec; 7(6):537-43. PubMed ID: 20035618
    [No Abstract]   [Full Text] [Related]  

  • 5. Three researchers developing therapies based on RNA interference talk about their experiences leaving academia for biotech companies.
    Bonetta L
    Biotechniques; 2007 Apr; 42(4 Suppl):S10-11, S16. PubMed ID: 18798733
    [No Abstract]   [Full Text] [Related]  

  • 6. Profile: William Haseltine.
    Herrera S
    Nat Biotechnol; 2005 Aug; 23(8):913. PubMed ID: 16082351
    [No Abstract]   [Full Text] [Related]  

  • 7. Abe Abuchowski.
    Katsnelson A
    Nat Biotechnol; 2006 Sep; 24(9):1050. PubMed ID: 16964200
    [No Abstract]   [Full Text] [Related]  

  • 8. Profile: Una Ryan.
    Schmidt C
    Nat Biotechnol; 2006 Aug; 24(8):881. PubMed ID: 16900115
    [No Abstract]   [Full Text] [Related]  

  • 9. Masters of their universe.
    Osborne R; DeFrancesco L
    Nat Biotechnol; 2009 Jun; 27(6):528-30. PubMed ID: 19513053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The biopharmaceutical industry in China: history and future perspectives.
    Gao K; Wang J
    Front Med; 2012 Jun; 6(2):101-11. PubMed ID: 22544299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Venter's departure sees Celera seek therapies.
    Dennis C
    Nature; 2002 Jan; 415(6871):461. PubMed ID: 11823816
    [No Abstract]   [Full Text] [Related]  

  • 12. Profile: Jean Deleage.
    Ratner M
    Nat Biotechnol; 2005 Oct; 23(10):1197. PubMed ID: 16211047
    [No Abstract]   [Full Text] [Related]  

  • 13. Profile: Alpheus Bingham.
    Wilan K
    Nat Biotechnol; 2007 Oct; 25(10):1072. PubMed ID: 17921979
    [No Abstract]   [Full Text] [Related]  

  • 14. Interview with Thomas P. Monath, M.D. Interview by Vicki Glaser.
    Monath TP
    Vector Borne Zoonotic Dis; 2005; 5(3):300-4. PubMed ID: 16187902
    [No Abstract]   [Full Text] [Related]  

  • 15. The socialite scientist.
    Serwer A
    Fortune; 2002 Apr; 145(8):152-4, 158, 160 passim. PubMed ID: 11961885
    [No Abstract]   [Full Text] [Related]  

  • 16. Ten years on--the European perspective. Biotech company founders talk about what made their companies tick.
    Collingham DP
    Biotechnology (N Y); 1993 Mar; 11(3):S44-6. PubMed ID: 7763435
    [No Abstract]   [Full Text] [Related]  

  • 17. Perspectives: biotechnology in Czech Republic, the past and the future.
    Damborský J; Prokop Z; Kostka M
    Biotechnol J; 2006 May; 1(5):487-90. PubMed ID: 16892283
    [No Abstract]   [Full Text] [Related]  

  • 18. Remembering Marvin Weinstein (1916-2011).
    Demain AL; Weinstein RN
    J Antibiot (Tokyo); 2012 Jul; 65(7):381-2. PubMed ID: 22836814
    [No Abstract]   [Full Text] [Related]  

  • 19. Profile: Jean-Paul Clozel.
    Schmidt C
    Nat Biotechnol; 2007 Feb; 25(2):155. PubMed ID: 17287737
    [No Abstract]   [Full Text] [Related]  

  • 20. "Extraordinary Measures": Arrowsmith for the NASDAQ era.
    Weissmann G
    FASEB J; 2010 Apr; 24(4):963-7. PubMed ID: 20356907
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.